Supplying natural, EU-GMP psilocybin and synthetic psychedelics for a world in need NASDAQ: OPTH
Princeton, British Columbia
Optimi Health Corp. (Nasdaq: OPTH) is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. As a Health Canada-licensed pharmaceutical manufacturer, Optimi produces validated MDMA and botanical psilocybin drug products at its GMP-compliant facilities in British Columbia, Canada. Optimi supplies both active pharmaceutical ingredients and finished dosage forms to regulated clinical and therapeutic programs internationally, with products currently prescribed to patients in Australia under the country’s Authorized Prescriber Scheme and accessible in Canada through the Special Access Program.
On-site · Princeton
Carry out GMP manufacturing steps for active pharmaceutical ingredients and finished products, including extraction, processing, packaging, equipment operation, and sanitation. Maintain accurate batch, equipment, cleaning, and inventory records; support controlled-substance controls, compliance investigations, maintenance, and cross-functional production activities.
On-site · Princeton
Perform bench-scale API synthesis, optimize reactions, troubleshoot procedures, and document experimental results while supporting process development and scale-up toward pilot and GMP-ready production. Research relevant scientific literature and patents, prepare technical summaries, and collaborate with chemistry, manufacturing, and operations teams.
